Bayesian Capital Management’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Buy
+1,300
New +$231K 0.16% 179
2025
Q4
Sell
-3,100
Closed -$410K 193
2025
Q3
$410K Buy
+3,100
New +$364K 0.08% 323
2025
Q1
Sell
-4,500
Closed -$465K 654
2024
Q4
$465K Buy
4,500
+2,462
+121% +$265K 0.06% 387
2024
Q3
$225K Sell
2,038
-46,800
-96% -$4.54M 0.03% 541
2024
Q2
$4.3M Buy
+48,838
New +$3.9M 0.49% 33
2024
Q1
Sell
-2,507
Closed -$217K 813
2023
Q4
$217K Buy
+2,507
New +$210K 0.02% 582

Other funds holding CHRW

Bayesian Capital Management's CHRW Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in C.H. Robinson (CHRW) in Q2 2026: 1,300 shares worth $245K. The stake represents 0.16% of the portfolio and ranks #179 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in CHRW as recently as Q3 2025.

Bayesian Capital Management first reported a position in CHRW in Q4 2023 and has held it in 6 quarters since. The position peaked at $4.3M in Q2 2024. 891 funds tracked by Wall St. Rank hold CHRW as of Q2 2026.

  • Bayesian Capital Management held 1,300 shares of C.H. Robinson worth $245K as of Q2 2026.
  • C.H. Robinson was a new Bayesian Capital Management position in Q2 2026.
  • C.H. Robinson made up 0.16% of Bayesian Capital Management's portfolio in Q2 2026, its #179 holding.
  • Bayesian Capital Management first reported a position in C.H. Robinson in Q4 2023 and has held it in 6 quarters since.
  • Bayesian Capital Management's C.H. Robinson position peaked at $4.3M in Q2 2024.
  • 891 funds tracked by Wall St. Rank held C.H. Robinson as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.